{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:06:37Z","timestamp":1793754397452,"version":"4.6.1"},"reference-count":295,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Hematopoiesis is a tightly regulated process that produces all adult blood cells and immune cells from multipotent hematopoietic stem cells (HSCs). HSCs usually remain quiescent, and in the presence of external stimuli like infection or inflammation, they undergo division and differentiation as a compensatory mechanism. Normal hematopoiesis is impacted by systemic inflammation, which causes HSCs to transition from quiescence to emergency myelopoiesis. At the molecular level, inflammatory cytokine signaling molecules such as tumor necrosis factor (TNF), interferons, interleukins, and toll-like receptors can all cause HSCs to multiply directly. These cytokines actively encourage HSC activation, proliferation, and differentiation during inflammation, which results in the generation and activation of immune cells required to combat acute injury. The bone marrow niche provides numerous soluble and stromal cell signals, which are essential for maintaining normal homeostasis and output of the bone marrow cells. Inflammatory signals also impact this bone marrow microenvironment called the HSC niche to regulate the inflammatory-induced hematopoiesis. Continuous pro-inflammatory cytokine and chemokine activation can have detrimental effects on the hematopoietic system, which can lead to cancer development, HSC depletion, and bone marrow failure. Reactive oxygen species (ROS), which damage DNA and ultimately lead to the transformation of HSCs into cancerous cells, are produced due to chronic inflammation. The biological elements of the HSC niche produce pro-inflammatory cytokines that cause clonal growth and the development of leukemic stem cells (LSCs) in hematological malignancies. The processes underlying how inflammation affects hematological malignancies are still not fully understood. In this review, we emphasize the effects of inflammation on normal hematopoiesis, the part it plays in the development and progression of hematological malignancies, and potential therapeutic applications for targeting these pathways for therapy in hematological malignancies.<\/jats:p>","DOI":"10.3389\/fonc.2024.1347402","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:53:17Z","timestamp":1710895997000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Inflammation as a driver of hematological malignancies"],"prefix":"10.3389","volume":"14","author":[{"given":"Sumedha","family":"Saluja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishu","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sabique","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth Kumar","family":"Palanichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17039","article-title":"Reparative inflammation takes charge of tissue regeneration","volume":"529","author":"Karin","year":"2016","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-019-00194-x","article-title":"Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles","volume":"10","author":"Qian","year":"2019","journal-title":"EPMA J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"N\u00f8st","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz587","article-title":"The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study","volume":"40","author":"Van\u2019T Klooster","year":"2019","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.711206","article-title":"Prognostic value of inflammatory biomarkers in patients with stage I lung adenocarcinoma treated with surgical dissection","volume":"11","author":"Shen","year":"2021","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171461","article-title":"Hematopoietic cytokines can instruct lineage choice","volume":"325","author":"Rieger","year":"2009","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12185-017-2266-5","article-title":"Impact of inflammation on early hematopoiesis and the microenvironment","volume":"106","author":"Takizawa","year":"2017","journal-title":"Int J Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.12.007","article-title":"The wolf in sheep\u2019s clothing: the role of interleukin-6 in immunity, inflammation and cancer","volume":"14","author":"Naugler","year":"2008","journal-title":"Trends Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2009.11.007","article-title":"The chemokine system in cancer biology and therapy","volume":"21","author":"Mantovani","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","article-title":"Cancer-related inflammation: common themes and therapeutic opportunities","volume":"22","author":"Balkwill","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2941","article-title":"The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells","volume":"67","author":"Kulbe","year":"2007","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/145293","article-title":"Pathogenesis of myeloproliferative neoplasms: role and mechanisms of chronic inflammation","volume":"2015","author":"Hermouet","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/ijms22115421","article-title":"Inflammation-induced tumorigenesis and metastasis","volume":"22","author":"Hibino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nri2726","article-title":"Awakening dormant haematopoietic stem cells","volume":"10","author":"Trumpp","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2011-12-380113","article-title":"Demand-adapted regulation of early hematopoiesis in infection and inflammation","volume":"119","author":"Takizawa","year":"2012","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103253","article-title":"Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells","volume":"188","author":"Boettcher","year":"2012","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0260-3","article-title":"Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis","volume":"20","author":"Yamashita","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essentialDevelopmental checkpoint in definitiveHematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.89","article-title":"Regulation of hematopoietic and leukemic stem cells by the immune system","volume":"22","author":"Riether","year":"2015","journal-title":"Cell Death Differ"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3647","article-title":"Hematopoietic stem cell niche maintenance during homeostasis and regeneration","volume":"20","author":"Mendelson","year":"2014","journal-title":"Nat Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.024","article-title":"Niches for hematopoietic stem cells and their progeny","volume":"48","author":"Wei","year":"2018","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0402-5","article-title":"Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation","volume":"20","author":"Chavakis","year":"2019","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000489406","article-title":"Myelopoiesis in the context of innate immunity","volume":"10","author":"Mitroulis","year":"2018","journal-title":"J Innate Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01540","article-title":"Regulation of the bone marrow niche by inflammation","volume":"11","author":"Mitroulis","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological Malignancies","volume":"20","author":"M\u00e9ndez-","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-670224","article-title":"Myeloid Malignancies and the microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"M\u00e9ndez-","year":"2010","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.07.004","article-title":"Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche","volume":"118","author":"Arai","year":"2004","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.06.001","article-title":"Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance","volume":"1","author":"Kiel","year":"2007","journal-title":"Cell Stem Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.053","article-title":"Nonmyelinating schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche","volume":"147","author":"Yamazaki","year":"2011","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3706","article-title":"Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells","volume":"20","author":"Zhao","year":"2014","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150057","article-title":"CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow","volume":"212","author":"Nakamura-Ishizu","year":"2015","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.10.095","article-title":"Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin","volume":"454","author":"Nakamura-Ishizu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"Bruns","year":"2014","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00502\/full","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570762","article-title":"Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis","volume":"124","author":"Boettcher","year":"2014","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.11.004","article-title":"Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging, and inflammation","volume":"29","author":"Helbling","year":"2019","journal-title":"Cell Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.01.004","article-title":"Regulation of inflammation- and infection-driven hematopoiesis","volume":"38","author":"Boettcher","year":"2017","journal-title":"Trends Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0272","article-title":"G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow","volume":"106","author":"Semerad","year":"2005","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2162-4","article-title":"Cellular players of hematopoietic stem cell mobilization in the bone marrow niche","volume":"105","author":"Tay","year":"2017","journal-title":"Int J Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253534","article-title":"Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs","volume":"116","author":"Winkler","year":"2010","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009016","article-title":"Pro-inflammatory cytokines, IFN\u03b3 and TNF\u03b1, influence immune properties of human bone marrow and wharton jelly mesenchymal stem cells differentially","volume":"5","author":"Prasanna","year":"2010","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-780882","article-title":"Inflammation: a key regulator of hematopoietic stem cell fate in health and disease","volume":"130","author":"Pietras","year":"2017","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2013.05.007","article-title":"Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation","volume":"11","author":"Heazlewood","year":"2013","journal-title":"Stem Cell Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.195396","article-title":"Updates on the hematologic tumor microenvironment and its therapeutic targeting","volume":"104","author":"Forte","year":"2019","journal-title":"Haematologica"},{"key":"B55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1471-2407-12-304","article-title":"Myeloid Malignancies: mutations, models and management","volume":"12","author":"Murati","year":"2012","journal-title":"BMC Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1592","article-title":"Leukaemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1597","article-title":"Concise review: leukemia stem cells in personalized medicine","volume":"32","author":"Guzman","year":"2014","journal-title":"Stem Cells"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-0348-0837-8_13","article-title":"The role of inflammation in leukaemia","volume-title":"Inflammation and cancer","author":"Krawczyk","year":"2014"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07648.x","article-title":"CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK","volume":"145","author":"Juarez","year":"2009","journal-title":"Br J Haematol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL\u2013expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062785","article-title":"TGF-\u03b2-neutralizing antibody 1D11 enhances cytarabine-induced apoptosis in AML cells in the bone marrow microenvironment","volume":"8","author":"Tabe","year":"2013","journal-title":"PloS One"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature08734","article-title":"TGF-\u03b2\u2013FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.06.020","article-title":"Inflammation and cancer: how friendly is the relationship for cancer patients","volume":"9","author":"Aggarwal","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401874","article-title":"Targeting NF-jB in hematologic Malignancies","volume":"13","author":"Braun","year":"2006","journal-title":"Cell Death Differ"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.08.016","article-title":"The immune landscape of myelodysplastic syndromes","volume":"107","author":"Fozza","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.617466","article-title":"Senescent mesenchymal stem cells in myelodysplastic syndrome: functional alterations, molecular mechanisms, and therapeutic strategies","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.02.015","article-title":"Persistently activated stat3 maintains constitutive NF-\u03baB activity in tumors","volume":"15","author":"Lee","year":"2009","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203479","article-title":"The role of STATs in myeloid differentiation and leukemia","volume":"19","author":"Coffer","year":"2000","journal-title":"Oncogene"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0125-z","article-title":"Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host","volume":"557","author":"Meisel","year":"2018","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01072-6","article-title":"Inhibitors targeting Bruton\u2019s tyrosine kinase in cancers: drug development advances","volume":"35","author":"Wen","year":"2021","journal-title":"Leukemia"},{"key":"B85","doi-asserted-by":"publisher","first-page":"114009","DOI":"10.1016\/j.ejmech.2021.114009","article-title":"Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib","volume":"229","author":"Ran","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-022-01353-w","article-title":"BTK inhibitors in the treatment of hematological Malignancies and inflammatory diseases: mechanisms and clinical studies","volume":"15","author":"Alu","year":"2022","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01252-4","article-title":"Zanubrutinib: first approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.004051","article-title":"Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory\/autoimmune diseases and hematological Malignancies","volume":"64","author":"Foster","year":"2012","journal-title":"Pharmacol Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0779-0","article-title":"Midostaurin: first global approval","volume":"77","author":"Kim","year":"2017","journal-title":"Drugs"},{"key":"B90","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.38","article-title":"Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma","volume":"3","author":"Chanan-Khan","year":"2013","journal-title":"Blood Cancer J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.18502\/ijaai.v18i2.924","article-title":"Inhibition of airway contraction and inflammation by pomalidomide in a male wistar rat model of ovalbumin-induced asthma","volume":"18","author":"Ghaderi","year":"2019","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2016.17.1.369","article-title":"Acute myeloid leukemia: clinical spectrum of 125 patients","volume":"17","author":"Sultan","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"B96","volume-title":"Myeloid Malignancies","author":"Howard","year":"2014"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v8i23","article-title":"The relevance of a low JAK2 V617F allele burden in clinical practice: a monocentric study","volume":"8","author":"Perricone","year":"2017","journal-title":"Oncotarget"},{"key":"B98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12943-018-0788-y","article-title":"Role of non receptor tyrosine kinases in hematological Malignances and its targeting by natural products","volume":"17","author":"Siveen","year":"2018","journal-title":"Mol Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2008.01.003","article-title":"Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo","volume":"2","author":"Fleming","year":"2008","journal-title":"Cell Stem Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.02.016","article-title":"JunB Protects against Myeloid Malignancies by Limiting Hematopoietic Stem Cell Proliferation and Differentiation without Affecting Self-Renewal","volume":"15","author":"Santaguida","year":"2009","journal-title":"Cancer Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.gde.2006.08.011","article-title":"Hematopoietic stem cell self-renewal","volume":"16","author":"Akala","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1182\/blood-2007-07-075168","article-title":"Signaling pathways governing stem-cell fate","volume":"111","author":"Blank","year":"2008","journal-title":"Blood"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1598","article-title":"JunB gene expression is inactivated by methylation in chronic myeloid leukemia","volume":"101","author":"Yang","year":"2003","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.252","article-title":"Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival","volume":"99","author":"Benekli","year":"2002","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203486","article-title":"STAT signaling in the pathogenesis and treatment of leukemias","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-017-0005-9","article-title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"B109","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.12.032","article-title":"High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2","volume":"35","author":"Chamuleau","year":"2011","journal-title":"Leuk Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403946","article-title":"On the TRAIL of a new therapy for leukemia","volume":"19","author":"Kaufmann","year":"2005","journal-title":"Leukemia"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.3058","article-title":"Expression of tumor necrosis factor\u2013related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis","volume":"98","author":"Zang","year":"2001","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2174\/138161210791033932","article-title":"Nutlins and ionizing radiation in cancer therapy","volume":"16","author":"Impicciatore","year":"2010","journal-title":"Curr Pharm Des"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.12.3900","article-title":"Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L\u2013induced apoptosis of human acute leukemia cells","volume":"96","author":"Wen","year":"2000","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.07.013","article-title":"IKK\u03b2 Links inflammation and tumorigenesis in a mouse model of colitis-associated cancer","volume":"118","author":"Greten","year":"2004","journal-title":"Cell"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/s41467-018-07551-w","article-title":"Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia","volume":"9","author":"Tron","year":"2018","journal-title":"Nat Commun"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2576-1","article-title":"MCL-1 is modulated in Crohn\u2019s disease fibrosis by miR-29b via IL-6 and IL-8","volume":"368","author":"Nijhuis","year":"2017","journal-title":"Cell Tissue Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010608317361","article-title":"Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells","volume":"19","author":"Fukuoka","year":"2001","journal-title":"Invest New Drugs"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31398","article-title":"Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"124","author":"Assi","year":"2018","journal-title":"Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0344-9","article-title":"dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of \u03b12 integrin inhibitor E7820 in patients with advanced solid tumors","volume":"34","author":"Milojkovic Kerklaan","year":"2016","journal-title":"Invest New Drugs"},{"key":"B125","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12885-021-08301-w","article-title":"The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin \u03b12 expression","volume":"21","author":"H\u00fclskamp","year":"2021","journal-title":"BMC Cancer"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182369","article-title":"E7820, an anti-cancer sulfonamide, in combination with venetoclax in patients with splicing factor mutant myeloid Malignancies: A phase II clinical trial","volume":"142","author":"Bewersdorf","year":"2023","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-binding protein network in acute myeloid leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4079","article-title":"Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic Malignancies","volume":"14","author":"Berger","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.345.345","article-title":"Pembrolizumab, a PD-1 inhibitor, in patients with myelodysplastic syndrome (MDS) after failure of hypomethylating agent treatment","volume":"128","author":"Garcia-Manero","year":"2016","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3763","article-title":"A multi-center phase I trial of ipilimumab in patients with myelodysplastic syndromes following hypomethylating agent failure","volume":"24","author":"Zeidan","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed\/refractory acute myeloid leukemia: A nonrandomized, open-label, phase II study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0307","article-title":"Phase I trial of autologous CAR-T cells targeting NKG2D ligands in patients with AML\/MDS and multiple myeloma","volume":"7","author":"Baumeister","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326405","article-title":"BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet","volume":"118","author":"Soverini","year":"2011","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005017","article-title":"Inflammation accelerates BCR-ABL1+ B-ALL development through upregulation of AID","volume":"6","author":"Zhang","year":"2022","journal-title":"Blood Adv"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S41786","article-title":"Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia","volume":"7","author":"Li","year":"2014","journal-title":"OncoTargets Ther"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0258","article-title":"Ponatinib\u2014A step forward in overcoming resistance in chronic myeloid leukemia","volume":"19","author":"Frankfurt","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.52","article-title":"Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice","volume":"23","author":"Chen","year":"2009","journal-title":"Leukemia"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"B140","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0145-2126(00)00141-7","article-title":"In vitro characterization of the hematopoietic system in pediatric patients with acute lymphoblastic leukemia","volume":"25","author":"Espinoza-Hern\u00e1ndez","year":"2001","journal-title":"Leuk Res"},{"key":"B141","doi-asserted-by":"publisher","first-page":"386165","DOI":"10.1155\/2015\/386165","article-title":"Bone marrow cells in acute lymphoblastic leukemia create a proinflammatory microenvironment influencing normal hematopoietic differentiation fates","volume":"2015","author":"Vilchis-Ordo\u00f1ez","year":"2015","journal-title":"BioMed Res Int"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22941","article-title":"Increased CCL2 and IL-8 in the bone marrow microenvironment in acute lymphoblastic leukemia","volume":"56","author":"de Vasconcellos","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02404.x","article-title":"Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells","volume":"111","author":"Clodi","year":"2000","journal-title":"Br J Haematol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-370114","article-title":"Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL","volume":"119","author":"Castro Alves","year":"2012","journal-title":"Blood"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404684","article-title":"CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment","volume":"21","author":"Juarez","year":"2007","journal-title":"Leukemia"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21370","article-title":"Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation","volume":"50","author":"Mowafi","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.03.011","article-title":"Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1\u03b1 (CXCL12)","volume":"35","author":"Freret","year":"2011","journal-title":"Leuk Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2009.12.001","article-title":"IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers","volume":"50","author":"Sasson","year":"2010","journal-title":"Cytokine"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-\u03b1 (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2436348100","article-title":"Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling","volume":"100","author":"Brown","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1588607","article-title":"Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia","volume":"21","author":"Williams","year":"2007","journal-title":"Genes Dev"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.333","article-title":"Whole-exome sequencing of pediatric acute lymphoblastic leukemia","volume":"26","author":"Lilljebj\u00f6rn","year":"2012","journal-title":"Leukemia"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-309070","article-title":"ETV6\/RUNX1 (TEL\/AML1) is a frequent prenatal first hit in childhood leukemia","volume":"117","author":"Zuna","year":"2011","journal-title":"Blood"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36428","article-title":"The TEL-AML1 leukemia fusion gene dysregulates the TGF-\u03b2 pathway in early B lineage progenitor cells","volume":"119","author":"Ford","year":"2009","journal-title":"J Clin Invest"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-465252","article-title":"STAT3 mediates oncogenic addiction to TEL-AML1 in t(12,21) acute lymphoblastic leukemia","volume":"122","author":"Mangolini","year":"2013","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"key":"B161","doi-asserted-by":"publisher","first-page":"101095","DOI":"10.1016\/j.beha.2019.101095","article-title":"How advanced are we in targeting novel subtypes of ALL","volume":"32","author":"Mullighan","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41467-017-00695-1","article-title":"BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells","volume":"8","author":"Combes","year":"2017","journal-title":"Nat Commun"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.257451","article-title":"LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia","volume":"107","author":"Gracia-Maldonado","year":"2022","journal-title":"Haematologica"},{"key":"B164","doi-asserted-by":"publisher","first-page":"502751","DOI":"10.1155\/2011\/502751","article-title":"Signaling proteins and transcription factors in normal and Malignant early B cell development","volume":"2011","author":"Perez-Vera","year":"2011","journal-title":"Bone Marrow Res"},{"key":"B165","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Hoelbl","year":"2010","journal-title":"EMBO Mol Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ph14050443","article-title":"Deregulation of the interleukin-7 signaling pathway in lymphoid Malignancies","volume":"14","author":"Lodewijckx","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.20.11464","article-title":"Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia","volume":"96","author":"McWhirter","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-292300","article-title":"Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance","volume":"116","author":"Chiu","year":"2010","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376061","article-title":"Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment","volume":"118","author":"Nwabo Kamdje","year":"2011","journal-title":"Blood"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/nature08020","article-title":"CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia","volume":"459","author":"Buonamici","year":"2009","journal-title":"Nature"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3606","article-title":"IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040789","article-title":"Activation of PI3K is indispensable for interleukin 7\u2013mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells","volume":"200","author":"Barata","year":"2004","journal-title":"J Exp Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1524","article-title":"Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1","volume":"98","author":"Barata","year":"2001","journal-title":"Blood"},{"key":"B176","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.leukres.2011.08.001","article-title":"Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy","volume":"36","author":"Tesfai","year":"2012","journal-title":"Leuk Res"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological Malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006136","article-title":"Decreased ADAMTS-13 level is related to inflammation factors and risk stratification of acute lymphoblastic leukemia patients","volume":"96","author":"Liu","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00545-5","article-title":"Targeting the JAK\/STAT pathway in T cell lymphoproliferative disorders","volume":"14","author":"Shouse","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.06.014","article-title":"Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor\u2013related apoptosis-inducing ligand-mediated apoptosis","volume":"38","author":"Akahane","year":"2010","journal-title":"Exp Hematol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/celldisc.2016.30","article-title":"NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K\u2013AKT and JAK\u2013STAT3 pathways","volume":"2","author":"Yuzugullu","year":"2016","journal-title":"Cell Discov"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085926","article-title":"CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12","volume":"9","author":"Melo R de","year":"2014","journal-title":"PloS One"},{"key":"B185","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jlb.62.1.82","article-title":"Cellular and viral protein interactions regulating I\u03baB\u03b1 activity during human retrovirus infection","volume":"62","author":"Hiscott","year":"1997","journal-title":"J Leukoc Biol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1126\/science.1299224","article-title":"Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B","volume":"258","author":"Kitajima","year":"1992","journal-title":"Science"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141018","article-title":"B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor","volume":"21","author":"Chiorazzi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"453634","DOI":"10.4061\/2009\/453634","article-title":"Gene expression and serum cytokine profiling of low stage CLL identify WNT\/PCP, flt-3L\/flt-3 and CXCL9\/CXCR3 as regulators of cell proliferation, survival and migration","volume":"2009","author":"Mahadevan","year":"2009","journal-title":"Hum Genomics Proteomics HGP"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.256","article-title":"Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome","volume":"97","author":"Fayad","year":"2001","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.666662","article-title":"Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia","volume":"53","author":"Yoon","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.11.3658.423k11_3658_3667","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1049","article-title":"Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cells","volume":"18","author":"Dietrich","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-02-0540","article-title":"Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway","volume":"103","author":"Kern","year":"2004","journal-title":"Blood"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/cancers12061396","article-title":"Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell Malignancies","volume":"12","author":"Efremov","year":"2020","journal-title":"Cancers"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4312","article-title":"Chronic lymphocytic leukemia: revelations from the B-cell receptor","volume":"103","author":"Stevenson","year":"2004","journal-title":"Blood"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.201","article-title":"Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells","volume":"24","author":"Suljagic","year":"2010","journal-title":"Leukemia"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)01046-9","article-title":"Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia","volume":"31","author":"Zaninoni","year":"2003","journal-title":"Exp Hematol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Stevenson","year":"2011","journal-title":"Blood"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-\u03baB substrate for prosurvival BLyS signaling","volume":"9","author":"Stadanlick","year":"2008","journal-title":"Nat Immunol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-431452","article-title":"Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor","volume":"121","author":"Reinart","year":"2013","journal-title":"Blood"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701553104","article-title":"IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival","volume":"104","author":"Binsky","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex","volume":"283","author":"Gore","year":"2008","journal-title":"J Biol Chem"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia: Presented in part at the 40th Annual Meeting of The American Society of Hematology, held in Miami Beach, FL, December 4-8, 1998","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848.418k05_1848_1854","article-title":"Unmutated ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1715","article-title":"ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia","volume":"105","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-011759","article-title":"ZAP-70 enhances B-cell\u2013receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells","volume":"109","author":"Gobessi","year":"2006","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12588","article-title":"Expression of ZAP 70 in chronic lymphocytic leukaemia activates NF -\u03baB signalling","volume":"163","author":"Pede","year":"2013","journal-title":"Br J Haematol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3390\/molecules28052400","article-title":"Bruton\u2019s tyrosine kinase inhibitors (BTKIs): review of preclinical studies and evaluation of clinical trials","volume":"28","author":"Rozkiewicz","year":"2023","journal-title":"Molecules"},{"key":"B215","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/cancers14010087","article-title":"FDA-approved drugs for hematological Malignancies\u2014The last decade review","volume":"14","author":"Sochacka-\u0106wik\u0142a","year":"2021","journal-title":"Cancers"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00491","article-title":"Phase II study of combination obinutuzumab, ibrutinib, and venetoclax in treatment-na\u00efve and relapsed or refractory chronic lymphocytic leukemia","volume":"38","author":"Rogers","year":"2020","journal-title":"J Clin Oncol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013208","article-title":"Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia","volume":"139","author":"Huber","year":"2022","journal-title":"Blood"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-853564","article-title":"Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia","volume":"132","author":"Rogers","year":"2018","journal-title":"Blood"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679134","article-title":"Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia","volume":"127","author":"Fraietta","year":"2016","journal-title":"Blood"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00305-7","article-title":"Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1\u20132 study","volume":"8","author":"Eyre","year":"2021","journal-title":"Lancet Haematol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016953","article-title":"Ventricular arrhythmias and sudden death events following acalabrutinib initiation","volume":"140","author":"Bhat","year":"2022","journal-title":"Blood"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.129","article-title":"RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins","volume":"17","author":"Fu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5397-z","article-title":"Dysregulation of TTP and HuR plays an important role in cancers","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0154","article-title":"Tristetraprolin Regulates Interleukin-6 Expression Through p38 MAPK-Dependent Affinity Changes with mRNA 3\u2032 Untranslated Region","volume":"31","author":"Zhao","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw474","article-title":"The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation","volume":"44","author":"Tiedje","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00031","article-title":"RNA-binding proteins in the control of LPS-induced macrophage response","volume":"10","author":"Ostareck","year":"2019","journal-title":"Front Genet"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5978","article-title":"RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence","volume":"352","author":"Galloway","year":"2016","journal-title":"Science"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200504","article-title":"Efficient homing of antibody-secreting cells to the bone marrow requires RNA-binding protein ZFP36L1","volume":"218","author":"Saveliev","year":"2021","journal-title":"J Exp Med"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1901","article-title":"Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia","volume":"11","author":"Hodson","year":"2010","journal-title":"Nat Immunol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.06.033","article-title":"Tristetraprolin impairs myc-induced lymphoma and abolishes the Malignant state","volume":"150","author":"Rounbehler","year":"2012","journal-title":"Cell"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1172\/JCI12973","article-title":"Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells","volume":"108","author":"Dixon","year":"2001","journal-title":"J Clin Invest"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404797","article-title":"Modulation of TNF -\u03b1 mRNA stability by human antigen R and miR181s in sepsis-induced immunoparalysis","volume":"7","author":"Dan","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2012.02.011","article-title":"HuR post-transcriptionally regulates TNF-\u03b1-induced IL-6 expression in human pulmonary microvascular endothelial cells mainly via tristetraprolin","volume":"181","author":"Shi","year":"2012","journal-title":"Respir Physiol Neurobiol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.4","article-title":"Posttranscriptional regulation of cancer traits by HuR","volume":"1","author":"Abdelmohsen","year":"2010","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B235","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2741\/3921","article-title":"HuR function in disease","volume":"17","author":"Srikantan","year":"2012","journal-title":"Front Biosci"},{"key":"B236","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1172\/JCI45021","article-title":"Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis","volume":"122","author":"Yiakouvaki","year":"2012","journal-title":"J Clin Invest"},{"key":"B237","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4291\/wjgp.v7.i1.131","article-title":"Role of nitric oxide in the pathogenesis of Barrett\u2019s-associated carcinogenesis","volume":"7","author":"Kusaka","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki797","article-title":"Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR","volume":"33","author":"Linker","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21856","article-title":"Significance of molecular markers in survival prediction of oral squamous cell carcinoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0764","article-title":"Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor huR","volume":"11","author":"Mrena","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9734-6","article-title":"Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer","volume":"28","author":"Wang","year":"2011","journal-title":"Med Oncol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0070","article-title":"Expression of the ELAV-like protein huR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma","volume":"10","author":"Denkert","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1987","article-title":"Overexpression of the embryonic-lethal abnormal vision-like protein huR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression","volume":"64","author":"Denkert","year":"2004","journal-title":"Cancer Res"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq052","article-title":"Role of the RNA-binding protein HuR in human renal cell carcinoma","volume":"31","author":"Danilin","year":"2010","journal-title":"Carcinogenesis"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3765","article-title":"Cytoplasmic huR expression is a prognostic factor in invasive ductal breast carcinoma","volume":"65","author":"Heinonen","year":"2005","journal-title":"Cancer Res"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1159\/000216837","article-title":"The expression of RNA-binding protein huR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis","volume":"76","author":"Wang","year":"2009","journal-title":"Oncology"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1097\/01.pgp.0000236946.82334.07","article-title":"Expression of huR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma","volume":"26","author":"Lim","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3115","article-title":"The RNA-binding protein HuR is essential for the B cell antibody response","volume":"16","author":"Diaz-Mu\u00f1oz","year":"2015","journal-title":"Nat Immunol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900377","article-title":"Control of thymic T cell maturation, deletion and egress by the RNA-binding protein huR","volume":"182","author":"Papadaki","year":"2009","journal-title":"J Immunol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.08.007","article-title":"HuR as a negative posttranscriptional modulator in inflammation","volume":"19","author":"Katsanou","year":"2005","journal-title":"Mol Cell"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.12.025","article-title":"Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPER\u03b1 and CAPER\u03b2","volume":"17","author":"Dowhan","year":"2005","journal-title":"Mol Cell"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2020.1711579","article-title":"Development of CAPER peptides for the treatment of triple negative breast cancer","volume":"19","author":"Chilewski","year":"2020","journal-title":"Cell Cycle"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00903-08","article-title":"CAPER\u03b1 Is a novel rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent rel\/NF-\u03baB oncoprotein v-rel","volume":"82","author":"Dutta","year":"2008","journal-title":"J Virol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.4161\/cc.28156","article-title":"CAPER, a novel regulator of human breast cancer progression","volume":"13","author":"Mercier","year":"2014","journal-title":"Cell Cycle"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.218289","article-title":"Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma Malignancy","volume":"105","author":"Tong","year":"2020","journal-title":"Haematologica"},{"key":"B256","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","article-title":"The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer","volume":"29","author":"Lederer","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80046","article-title":"RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation","volume":"126","author":"Palanichamy","year":"2016","journal-title":"J Clin Invest"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.588101","article-title":"Diagnostic utility of IGF2BP1 and its targets as potential biomarkers in ETV6-RUNX1 positive B-cell acute lymphoblastic leukemia","volume":"11","author":"Sharma","year":"2021","journal-title":"Front Oncol"},{"key":"B260","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-018-0628-y","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer","volume":"11","author":"Huang","year":"2018","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-15-0224","article-title":"Loss of stromal IMP1 promotes a tumorigenic microenvironment in the colon","volume":"13","author":"Hamilton","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B262","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-022-00343-5","article-title":"RNA binding proteins in MLL-rearranged leukemia","volume":"11","author":"Tran","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B263","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-023-02810-1","article-title":"RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia","volume":"42","author":"Sharma","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0656-9","article-title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1","volume":"34","author":"Elcheva","year":"2020","journal-title":"Leukemia"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872252","article-title":"m6A reader igf2bp1 regulates the inflammatory responses of microglia by stabilizing gbp11 and cp mRNAs","volume":"13","author":"Ding","year":"2022","journal-title":"Front Immunol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B267","doi-asserted-by":"publisher","first-page":"2100209","DOI":"10.1002\/advs.202100209","article-title":"The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPAR \u03b3","volume":"8","author":"Wang","year":"2021","journal-title":"Adv Sci"},{"key":"B268","doi-asserted-by":"publisher","first-page":"114179","DOI":"10.1016\/j.addr.2022.114179","article-title":"The RNA-binding protein HuR in human cancer: A friend or foe","volume":"184","author":"Wu","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"B269","doi-asserted-by":"publisher","first-page":"114442","DOI":"10.1016\/j.addr.2022.114442","article-title":"HuR as a molecular target for cancer therapeutics and immune-related disorders","volume":"188","author":"Majumder","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"B270","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","article-title":"Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential","volume":"11","author":"Zhu","year":"2023","journal-title":"biomark Res"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711633","article-title":"Post-transcriptional regulation of immune responses and inflammatory diseases by RNA-binding ZFP36 family proteins","volume":"12","author":"Makita","year":"2021","journal-title":"Front Immunol"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33057","article-title":"ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity","volume":"7","author":"Moore","year":"2018","journal-title":"eLife"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140510015","article-title":"Multiple functions of the RNA-binding protein huR in cancer progression, treatment responses and prognosis","volume":"14","author":"Wang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B274","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12885-023-10832-3","article-title":"Expression characteristics and their functional role of IGFBP gene family in pan-cancer","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01148-9","article-title":"The biological function of IGF2BPs and their role in tumorigenesis","volume":"39","author":"Du","year":"2021","journal-title":"Invest New Drugs"},{"key":"B276","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-021-00598-7","article-title":"RNA-binding protein 39: a promising therapeutic target for cancer","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Discov"},{"key":"B277","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.3390\/ijms23179552","article-title":"The role of RNA-binding proteins in hematological Malignancies","volume":"23","author":"Aguilar-Garrido","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2007.14","article-title":"Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR","volume":"3","author":"Meisner","year":"2007","journal-title":"Nat Chem Biol"},{"key":"B279","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.trsl.2016.02.007","article-title":"Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration","volume":"172","author":"Moradi","year":"2016","journal-title":"Transl Res"},{"key":"B280","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/1541-7786.MCR-15-0448","article-title":"HuR contributes to TRAIL resistance by restricting death receptor 4 expression in pancreatic cancer cells","volume":"14","author":"Romeo","year":"2016","journal-title":"Mol Cancer Res"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1591673","article-title":"Anti-cancer effects of the HuR inhibitor, MS-444, in Malignant glioma cells","volume":"20","author":"Wang","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.12.020","article-title":"Terminal adenosyl transferase activity of posttranscriptional regulator huR revealed by confocal on-bead screening","volume":"386","author":"Meisner","year":"2009","journal-title":"J Mol Biol"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13110","article-title":"The induced RNA-binding protein, HuR, targets 3\u2032-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis","volume":"192","author":"Ouhara","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B284","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3858\/emm.2009.41.11.088","article-title":"Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-\u03b1 mRNA","volume":"41","author":"Chae","year":"2009","journal-title":"Exp Mol Med"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072426","article-title":"A novel high throughput biochemical assay to evaluate the huR protein-RNA complex formation","volume":"8","author":"D\u2019Agostino","year":"2013","journal-title":"PloS One"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.100701","article-title":"Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells","volume":"89","author":"Latorre","year":"2016","journal-title":"Mol Pharmacol"},{"key":"B287","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1038\/srep16478","article-title":"Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function","volume":"5","author":"D\u2019Agostino","year":"2015","journal-title":"Sci Rep"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx623","article-title":"Regulation of HuR structure and function by dihydrotanshinone-I","volume":"45","author":"Lal","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.797878","article-title":"(HuR) multimerization contributes to glioma disease progression","volume":"292","author":"Filippova","year":"2017","journal-title":"J Biol Chem"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1021\/cb500851u","article-title":"Identi\u2019cation and validation of novel small molecule disruptors of huR-mRNA interaction","volume":"10","author":"Wu","year":"2015","journal-title":"ACS Chem Biol"},{"key":"B291","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/cancers11122014","article-title":"HuR reduces radiation-induced DNA damage by enhancing expression of ARID1A","volume":"11","author":"Andrade","year":"2019","journal-title":"Cancers"},{"key":"B292","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1038\/s41598-017-07787-4","article-title":"HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells","volume":"7","author":"Muralidharan","year":"2017","journal-title":"Sci Rep"},{"key":"B293","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1038\/s41598-019-43894-0","article-title":"The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells","volume":"9","author":"Allegri","year":"2019","journal-title":"Sci Rep"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1877","article-title":"Suramin, screened from an approved drug library, inhibits HuR functions and attenuates Malignant phenotype of oral cancer cells","volume":"7","author":"Kakuguchi","year":"2018","journal-title":"Cancer Med"},{"key":"B295","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-007-9751-0","article-title":"Trichostatin A and 5 Aza-2\u2032 deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR","volume":"111","author":"Pryzbylkowski","year":"2008","journal-title":"Breast Cancer Res Treat"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1347402\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:53:24Z","timestamp":1710896004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1347402\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":295,"alternative-id":["10.3389\/fonc.2024.1347402"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1347402","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"1347402"}}